Keyphrases
Diabetes
100%
Double-blind Placebo-controlled Trial
100%
Glycemic Control
100%
Nortriptyline
100%
Mental Health
25%
Placebo
25%
Major Depressive Disorder
25%
Path Analysis
25%
Medical Outcomes
25%
Glycated Hemoglobin
25%
Diabetic Patients
25%
Depressive Symptoms
12%
Randomized Placebo-controlled Trial
12%
Glucose Control
12%
Compliance Behavior
12%
Beck Depression inventory-II (BDI-II)
12%
Beneficial Effects
12%
Double-blind Trial
12%
Plasma Parameters
12%
Weight Change
12%
Antidepressants
12%
Chronic Conditions
12%
Depressed Patients
12%
Diabetes Management
12%
Self-monitoring of Blood Glucose
12%
Glucose Regulation
12%
Poor Compliance
12%
Dispensing Equipment
12%
Glycated Hemoglobin Levels
12%
Suboptimal Glycemic Control
12%
Glucometer
12%
Hyperglycemic Effects
12%
Therapeutic Plasma
12%
Regulation Compliance
12%
Electronic Memory
12%
Medication Dispensing
12%
Psychology
Mental Health
100%
Major Depressive Disorder
100%
Major Depression
100%
Major Depressive Episode
100%
Beck Depression Inventory
50%
Blood Glucose
50%
Self-Monitoring
50%
Nursing and Health Professions
Placebo
100%
Nortriptyline
100%
Compliance
37%
Glycosylated Hemoglobin
37%
Mental Health
25%
Diabetes Mellitus
25%
Major Depression
25%
Glucose Blood Level
12%
Hemoglobin Blood Level
12%
Self Monitoring
12%
Glucometer
12%
Blood Level
12%
Beck Depression Inventory
12%
Antidepressant
12%
Neuroscience
Placebo
100%
Nortriptyline
100%
Glycosylated Hemoglobin
37%
Diabetes Mellitus
25%
Major Depressive Disorder
25%
Behavior (Neuroscience)
12%
Beck Depression Inventory
12%
Antidepressant
12%
Blood Plasma
12%